The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors-Reference-Cited by-同舟云学术

The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors

Published:2011-04-14 Issue:9 Volume:28 Page:2147-2156
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Maillet Agnès,Guilleminault Laurent,Lemarié Etienne,Lerondel Stéphanie,Azzopardi Nicolas,Montharu Jérôme,Congy-Jolivet Nicolas,Reverdiau Pascale,Legrain Brigitte,Parent Christelle,Douvin Dominique-Henri,Hureaux José,Courty Yves,De Monte Michèle,Diot Patrice,Paintaud Gilles,Le Pape Alain,Watier Hervé,Heuzé-Vourc’h Nathalie

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s11095-011-0442-5.pdf

Reference33 articles.

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71–96.

2. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008;359(13):1367–80.

3. Janku F, Stewart DJ, Kurzrock R. Targeted therapy in non-small-cell lung cancer-is it becoming a reality? Nat Rev Clin Oncol. 2010;7(7):401–14.

4. Thatcher N. The place of targeted therapy in the patient management of non-small cell lung cancer. Lung Cancer. 2007;57 Suppl 2:S18–23.

5. Gagnadoux F, Hureaux J, Vecellio L, Urban T, Le Pape A, Valo I, et al. Aerosolized chemotherapy. J Aerosol Med. 2008;21(1):61–70.

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergy between Lactobacillus murinus and anti-PcrV antibody delivered in the airways to boost protection against Pseudomonas aeruginosa;Molecular Therapy - Methods & Clinical Development;2024-12

2. Biologics, theranostics, and personalized medicine in drug delivery systems;Pharmacological Research;2024-03

3. Developing a flowchart to evaluate the use of Closed System Drug-Transfer Devices with monoclonal antibodies: Focus on the clinical trial setting;Journal of Oncology Pharmacy Practice;2023-09-08

4. Barriers for orally inhaled therapeutic antibodies;Expert Opinion on Drug Delivery;2023-08-03

5. Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseases;Expert Opinion on Drug Delivery;2023-08-03